Thousands of people with type 1 diabetes could be offered wearable technology to help them manage their condition following the publication of final draft guidance by NICE.
NICE has launched its refreshed support service for the life sciences sector, NICE Advice.
NICE’s methods and processes now include a proportionate approach to technology appraisals, and a new way of updating recommendations on COVID-19 treatments.
Around 900 adults with advanced Parkinson’s are set to benefit from new treatment foslevodopa–foscarbidopa after NICE approved it for NHS use in final draft guidance published today (26 October 2023).
People who have had a stroke and who have continuing impairment or limitations on their activities should be offered additional rehabilitation to help them recover
More than 700 people set to benefit from new treatment option for advanced lymphoma.
Page 9 of 31